Skip to main content
Log in

Casper vs. Closed-Cell Stent

Carotid Artery Stenting Randomized Trial

  • Original Article
  • Published:
Clinical Neuroradiology Aims and scope Submit manuscript

Abstract

Objective

The aim of this trial was to compare the efficacy of closed-cell stents with Casper stents during carotid angioplasty stenting (CAS).

Methods

This was a randomized superiority trial in which 88 patients were enrolled. The primary end points were the incidence, number, and size of new ischemic brain lesions after CAS under distal embolic protection devices (EPD). The secondary end points included stroke, transient ischemic attack (TIA) and myocardial infarction (MI). Ischemic brain lesions were assessed by a diffusion-weighted magnetic resonance image (DW-MRI). Neurological outcomes were evaluated by means of the National Institutes of Health scale score (NIHSS) and the modified Rankin scale (mRS).

Results

Compared with closed-cell stents (n = 47), Casper stents (n = 41), resulted in no significant reduction in the incidence (44.7% versus 39%, P = 0.592), number (1.3 ± 1.8 versus 0.9 ± 1.5, p = 0.444), and size (3.9 ± 5.8 mm versus 2.8 ± 4.1 mm, p = 0.353) of new ischemic brain lesions. The global rate of stroke/TIA/MI was (2/88, 2.3%). Two TIA occurred during the hospitalization period, one in each group (1/41, 2.4% vs 1/47, 2.1%). One patient of the Casper group had an asymptomatic in-stent thrombosis. One patient of the control group had a MI (1/47, 2.1%) after discharge.

Conclusion

The Casper stents did not show superiority in the rate of incidence, number and size of new silent ischemic brain lesions detect by DW-MRI when compared to close cell stents during CAS under distal EPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711–20.

  2. Mantese VA, Timaran CH, Chiu D, Begg RJ, Brott TG, CREST Investigators. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke. 2010;41(10 Suppl):S31–4.

    PubMed  PubMed Central  Google Scholar 

  3. Jones MR, Howard G, Roubin GS, Blackshear JL, Cohen DJ, Cutlip DE, et al. Periprocedural stroke and myocardial infarction as risks for long-term mortality in CREST. Circ Cardiovasc Qual Outcomes. 2018;11:e004663.

    Article  Google Scholar 

  4. Schnaudigel S, Groschel K, Pilgram SM, Kastrup A. New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke. 2008;39:1911–9.

    Article  Google Scholar 

  5. Gensicke H, van der Worp HB, Nederkoorn PJ, Macdonald S, Gaines PA, van der Lugt A, et al. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol. 2015;65:521–9.

    Article  Google Scholar 

  6. Stabile E, Giugliano G, Cremonesi A, Bosiers M, Reimers B, Setacci C, et al. Impact on outcome of different types of carotid stent: results from the European Registry of Carotid Artery Stenting. EuroIntervention. 2016;12:e265–70.

    Article  Google Scholar 

  7. Timaran CH, Rosero EB, Higuera A, Ilarraza A, Modrall JG, Clagett GP. Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. J Vasc Surg. 2011;54:1310-1316. discussion 1316.

    Article  Google Scholar 

  8. Broussalis E, Griessenauer C, Mutzenbach S, Pikija S, Jansen H, Stevanovic V, et al. Reduction of cerebral DWI lesion burden after carotid artery stenting using the CASPER stent system. J Neurointerv Surg. 2019;11:62–7.

    Article  Google Scholar 

  9. Ruffino MA, Faletti R, Bergamasco L, Fonio P, Righi D. Incidence of new ischaemic brain lesions after carotid artery stenting with the micromesh roadsaver carotid artery stent: a prospective single-centre study. Cardiovasc Intervent Radiol. 2016;39:1541–9.

    Article  Google Scholar 

  10. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55.

    Article  Google Scholar 

  11. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318–22.

    Article  CAS  Google Scholar 

  12. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.

    Article  Google Scholar 

  13. de Castro-Afonso LH, Nakiri GS, Monsignore LM, dos Santos AC, Leite JP, Fábio SR, et al. Early versus late carotid artery stenting for symptomatic carotid stenosis. J Neuroradiol. 2015;42:169–75.

    Article  Google Scholar 

  14. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010;9:353–62. Erratum in: Lancet Neurol. 2010;9:345.

    Article  Google Scholar 

  15. Hopf-Jensen S, Marques L, Preiß M, Müller-Hülsbeck S. Initial clinical experience with the micromesh roadsaver carotid artery stent for the treatment of patients with symptomatic carotid artery disease. J Endovasc Ther. 2015;22:220–5.

    Article  Google Scholar 

  16. Wissgott C, Schmidt W, Brandt C, Behrens P, Andresen R. Preliminary clinical results and mechanical behavior of a new double-layer carotid stent. J Endovasc Ther. 2015;22:634–9.

    Article  Google Scholar 

  17. American College of Cardiology Foundation; American Society of Interventional & Therapeutic Neuroradiology; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology, Bates ER, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol. 2007;49:126–70. Erratum in: J Am Coll Cardiol. 2007;49:924.

    Article  Google Scholar 

  18. Schofer J, Musiałek P, Bijuklic K, Kolvenbach R, Trystula M, Siudak Z, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv. 2015;8:1229–34.

    Article  Google Scholar 

  19. Ruffino MA, Faletti R, Fronda M, Gatti M, Bergamasco L, Gibello L, et al. Early Embolization After Carotid Artery Stenting with Mesh-Covered Stent: Role of Diffusion-Weighted Magnetic Resonance Imaging as Pre-procedural Predictor and Discriminant Between Intra- and Post-procedural Events. Cardiovasc Intervent Radiol. 2019;42:812-9.

    Article  CAS  Google Scholar 

  20. Mutzenbach SJ, Millesi K, Roesler C, Broussalis E, Pikija S, Sellner J, et al. The Casper Stent System for carotid artery stenosis. J Neurointerv Surg. 2018;10:869–73.

    Article  Google Scholar 

  21. de Castro-Afonso LH, Abud LG, Rolo JG, Santos AC, Oliveira LD, Barreira CM, et al. Flow reversal versus filter protection: a pilot carotid artery stenting randomized trial. Circ Cardiovasc Interv. 2013;6:552–9.

    Article  Google Scholar 

  22. Hauth EA, Jansen C, Drescher R, Schwartz M, Forsting M, Jaeger HJ, et al. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. AJNR Am J Neuroradiol. 2005;26:2336–41.

    PubMed  PubMed Central  Google Scholar 

  23. Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, et al. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke. 2015;46:3288–301.

    Article  Google Scholar 

  24. Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, et al. The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery. EuroIntervention. 2016;12:e671–6.

    Article  Google Scholar 

  25. de Donato G, Setacci F, Sirignano P, Galzerano G, Cappelli A, Setacci C. Optical coherence tomography after carotid stenting: rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013;45:579–87.

    Article  Google Scholar 

  26. Schillinger M, Gschwendtner M, Reimers B, Trenkler J, Stockx L, Mair J, et al. Does carotid stent cell design matter? Stroke. 2008;39:905–9.

    Article  Google Scholar 

  27. Skjelland M, Krohg-Sørensen K, Tennøe B, Bakke SJ, Brucher R, Russell D. Cerebral microemboli and brain injury during carotid artery endarterectomy and stenting. Stroke. 2009;40:230–4.

    Article  Google Scholar 

  28. Kotsugi M, Takayama K, Myouchin K, Wada T, Nakagawa I, Nakagawa H, et al. Carotid artery stenting: investigation of plaque protrusion incidence and prognosis. JACC Cardiovasc Interv. 2017;10:824–31.

    Article  Google Scholar 

  29. Yamada K, Yoshimura S, Miura M, Kanamaru T, Shindo S, Uchida K, et al. Potential of new-generation double-layer micromesh stent for carotid artery stenting in patients with unstable plaque: a preliminary result using OFDI analysis. World Neurosurg. 2017;105:321–6.

    Article  Google Scholar 

  30. Capodanno D, Patel A, Dharmashankar K, Ferreiro JL, Ueno M, Kodali M, et al. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. Circ Cardiovasc Interv. 2011;4:180–7.

    Article  CAS  Google Scholar 

  31. Yilmaz U, Körner H, Mühl-Benninghaus R, Simgen A, Kraus C, Walter S, et al. Acute occlusions of dual-layer carotid stents after endovascular emergency treatment of tandem lesions. Stroke. 2017;48:2171–5.

    Article  Google Scholar 

  32. Pfaff JAR, Maurer C, Broussalis E, Janssen H, Blanc R, Dargazanli C, et al. Acute thromboses and occlusions of dual layer carotid stents in endovascular treatment of tandem occlusions. J Neurointerv Surg. 2020;12:33–7.

    Article  Google Scholar 

  33. Lamanna A, Maingard J, Kok HK, Barras C, Jhamb A, et al. Carotid artery stenting in acute stroke using a microporous stent device: a single-center experience. World Neurosurg. 2019;127:e1003–12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Ricardo Vanzin.

Ethics declarations

Conflict of interest

J.R. Vanzin, L.H. de Castro-Afonso, M.N. Santos, L.B. Manzato, G.S. Nakiri, L.M. Monsignore, F.P. Trivelato, M.T.S. Rezende, O.M. Pontes-Neto and D.G. Abud declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vanzin, J.R., de Castro-Afonso, L.H., Santos, M.N. et al. Casper vs. Closed-Cell Stent. Clin Neuroradiol 31, 843–852 (2021). https://doi.org/10.1007/s00062-020-00937-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00062-020-00937-8

Keywords

Navigation